NDC 71785-1007-01 - VENLAFAXINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71785-1007
- Requested NDC
- 71785-1007-01
- Package NDCs from labels
- 71785-1007-0, 71785-1007-1, 71785-1007-2, 71785-1007-3, 71785-1007-01
- Manufacturer
- Annora Pharma Private Limited
- Effective date
- 2020-11-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE - Annora Pharma Private Limited | Annora Pharma Private Limited | 2020-11-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71785-1007-0 | VENLAFAXINE HYDROCHLORIDE | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | 3 | |
| 71785-1007-1 | VENLAFAXINE HYDROCHLORIDE | 90 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 90 | 3 | |
| 71785-1007-2 | VENLAFAXINE HYDROCHLORIDE | 500 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 500 | 3 | |
| 71785-1007-3 | VENLAFAXINE HYDROCHLORIDE | 10 in 1 BLISTER PACK | CAPSULE, EXTENDED RELEASE | 10 | 3 | |
| 71785-1007-3 | VENLAFAXINE HYDROCHLORIDE | 10 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71785-1007 | VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [ANNORA PHARMA PRIVATE LIMITED] | 3 | Current NDC, Legacy NDC, 5 package rows | 20201202_e901e476-58bd-4204-baaa-a4634ae65ab3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.